Home › Trial NCT00923507
Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
- Trial IDNCT00923507
- StatusRecruiting
- PhaseN/A
- Study typeObservational
- SponsorNational Heart, Lung, and Blood Institute (NHLBI)
- Enrollment1000
- Start date2008-05-29
- ConditionsWaldenstrom Macroglobulinemia · Lymphoplasmacytic Lymphoma · Monoclonal B-Cell Lymphocytosis · Small Lymphocytic Lymphoma · CLL (Chronic Lymphocytic Leukemia)
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.